The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Software Integration Resources
EMPOWERING PRESCRIBERS AND DISPENSERS TO PREVENT OPIATE ABUSE
The cost for integration of MAPS into an existing electronic medical records (EMR) and a pharmacy dispensation systems (PDS) has been extended through at least April 7, 2024.
If you have already submitted an Integration Request Form and Terms and Conditions, please do not complete the below steps. The primary point of contact will be notified if additional steps are needed, and those with a countersigned terms and conditions will be notified and provided an Addendum to the Terms and Conditions to be signed and returned.
1. Click Create an Account in the top right-hand corner of the page in the Customer Connect Portal.
2. Follow the on-screen prompts to gather the needed information for your integration request.
3. Within Customer Connect, you will be sent an email to e-sign the Terms and Conditions via HelloSign.
4. The State will receive and countersign the Terms and Conditions. You will receive a confirmation email via HelloSign once this happens, along with a copy of the full executed Terms and Conditions.
5. Upon receipt of your completed request, Bamboo Health (formerly known as Appriss Health) will submit your request to the State for review and final approval.
6. Upon State approval, credentials will be sent to your primary point of contact and/or your EMR/EHR or Pharmacy System vendor, per your vendor's onboarding instructions.
7. A confirmation email will be sent to your primary point of contact, and then you will need to work with your vendor on next steps and completion of your integration.
The State of Michigan is covering the full cost of integration of MAPS into the clinical workflow of health systems, physician groups and pharmacies until August 31, 2023. Learn how to start the integration process.
If your question(s) pertain to the new opioid legislation, we encourage you to review the recently-released FAQs. Additional questions or concerns can be addressed by contacting MAPS.